<style>
  
#bubble {
top:40px;
right:0;
position:absolute;
display:block;
height:28px;
background:url(images/bubble_right.gif) no-repeat right;
}

#bubble p {
display:block;
font-size:11px;
color:#fff;
height:28px;
padding:4px 12px 0 10px;
background:url(images/bubble_left.gif) no-repeat top left;
}

#content {
margin-top: 20px;
background: #fff!important;
float:left;
/*width:578px;*/
width:71%;
}

#content h2 {
	color: #000;
	font-size: 18px;
	font-weight: 700;
}

#content h2 a {
text-decoration:none;
}

#content h2 a:hover {
text-decoration:underline;
}

#content h2.archive {
font-weight:normal;
font-size:22px;
color:#1c1c1c;
padding:0;
margin:5px 0 20px 0;
border:none;
text-align:left;
}

.comments {
color:#333;
margin:0 0 15px 0;
border-bottom:#bbb 1px solid;
}

.comments a {
background:#fff;
padding:0 7px 5px 0;
color:#333;
text-decoration:none;
}

.comments a:hover {
color:#c00;
}

.navigation {
background:#f9f9f9;
font-size:11px;
padding:5px 10px;
margin:0 0 20px 0;
border-top:#bbb 1px solid;
}

.navigation a {
color:#555;
font-weight:bold;
text-decoration:none;
}

.navigation a:hover {
color:#333;
text-decoration:none;
}

.main h3 {
font-size:16px;
font-weight:normal;
margin:0 0 15px 0;
}

.main img {
padding:2px;
border:#ddd 2px solid;
}

.main a img {
padding:2px;
border:#0085b5 2px solid;
}

.main a:hover img {
padding:2px;
border:#ca0002 2px solid;
}

.main p {
line-height:18px;
margin:0 0 15px 0;
}

.main ol {
line-height:18px;
margin:0 0 15px 30px;
}

.main ul {
line-height:18px;
margin:0 0 15px 30px;
}

.main li {
margin:0 0 5px 0;
}

.meta {
background:#f3f3f3;
font-size:11px;
line-height:15px;
color:#333;
padding:5px 10px;
margin:0 0 30px 0;
border-top:#bbb 1px solid;
}

.signature {
float:left;
padding:0 15px 0 0;
border-right:#bbb 1px solid;
width:200px;
}

.tags {
float:left;
padding:0 0 0 15px;
width:440px;
}

#sidebar {
background: #323232;
border-bottom-right-radius: 30px;
margin-top: 20px;
font-size:12px;
float:right;
width:284px;
padding: 15px;
color: white;
}

#sidebar a {
	color: #DBA922;
}

#sidebar h3 {
display: block;
color: white;
font-size:14px;
margin:20px 0 10px 0;
}

#sidebar ul {
list-style:none;
padding: 0 0 0 20px;
margin: 0;
}

#sidebar ul ul {
margin:5px 0 0 10px;
}

#sidebar ul ul ul {
margin:5px 0 0 10px;
}

#sidebar ul li {
padding: 0;
margin: 0;
}

#author h3 {
margin:5px 0 5px 0;
}

#searchform {
margin:15px 0 0 0;
}

#searchform input {
background:#222;
font-size:11px;
margin:2px 0;
padding:1px 4px 2px 4px;
border:#888 1px solid;
color:#eee;
}

#searchform input:hover {
background:#333;
border:#999 1px solid;
color:#fff;
cursor:pointer;
}

#searchform #s {
background:#f6f6f6;
font-size:11px;
margin:2px 0;
padding:2px 4px;
border:#aaa 1px solid;
color:#222;
}

#searchform #s:hover {
border:#c00 1px solid;
cursor:text;
}

input.searchfield {
background:#f6f6f6;
font-size:11px;
display:block;
margin:5px 0 8px 0;
padding:2px 4px;
border:#aaa 1px solid;
color:#222;
}

input.searchfield:hover {
background:#eee;
color:#222;
}

input.submit {
background:#222;
font-size:11px;
display:block;
margin:0 0 10px 0;
padding:1px 4px 2px 4px;
border:#888 1px solid;
color:#eee;
}

input.submit:hover {
background:#333;
cursor:pointer;
border:#999 1px solid;
color:#fff;
}

input.subcom {
background:#eee;
font-size:11px;
margin:0 0 10px 0;
padding:1px 4px 2px 4px;
border:#888 1px solid;
color:#222;
}

input.subcom:hover {
background:#222;
cursor:pointer;
border:#888 1px solid;
color:#eee;
}

input.comment {
background:#f6f6f6;
font-size:11px;
padding:2px 4px;
border:#aaa 1px solid;
color:#222;
}

input.comment:hover {
border:#c00 1px solid;
}

textarea {
background:#f6f6f6;
font-size:12px;
width:400px;
padding:2px 4px;
border:#aaa 1px solid;
color:#222;
}

textarea:hover {
border:#c00 1px solid;
}

.postinput small {
font-size:11px;
margin:0 0 0 5px;
}

p.logged {
font-size:12px;
}

h3.reply {
font-size:15px;
margin:0 0 10px 0;
}

.nocomments {
margin:0 0 30px 0;
}

ol.commentlist {
font-size:12px;
list-style:none;
margin:10px 0 30px 0;
border-bottom:#bbb 1px solid;
}

.commentlist li {
border-top:#bbb 1px solid;
padding:0 0 10px 0;
}

.commentlist li.bypostauthor {
border-top:#bbb 5px solid;
background-color:#f3f3f3;
}

.comment_mod {
margin:10px 0 0 10px;
}

.comment_mod em {
background-color:#fff897;
padding:1px 3px;
}

.comment_author {
margin:10px 0;
float:right;
width:190px;
}

.comment_author img {
float:left;
margin:5px 12px 0 0;
}

.comment_author p {
line-height:20px;
}

.comment_author small {
font-size:11px;
}

.comment_text {
float:left;
width:470px;
margin:0 0 0 10px;
}

.comment_text p {
line-height:18px;
margin:7px 0;
}

.comment_meta {
font-size:12px;
}

#commentform p {
line-height:18px;
margin:0 0 15px 0;
}

blockquote {
background:url(images/quote.gif) no-repeat top left;
padding:0 0 0 60px;
min-height:50px;
}

.clear {
clear:both;
}

.warning p {
background:url(images/warning.gif) no-repeat left;
height:160px;
padding:20px 0 0 90px;
font-size:20px;
margin:0 0 0 10px;
}

#wp-calendar {
padding:10px 0 0 0;
font-size:12px;
}

#wp-calendar caption {
text-align:left;
padding:0 0 5px 0;
}

#wp-calendar tr th,
#wp-calendar tr td {
padding:0 6px 0 0 ;
text-align:right;
}

#wp-calendar td a {
font-weight:bold;
}

#wp-calendar td a:hover {
font-weight:bold;
}

img.wp-smiley {
padding:0;
border:none;
}

input:focus, textarea:focus{
background-color:#ffc;
}

abbr {
border:none;
}

.aligncenter {
display: block;
margin-left: auto;
margin-right: auto;
}

.alignleft {
float:left;
}

.alignright {
float:right;
}

.wp-caption {
border:1px solid #ddd;
text-align:center;
background-color:#f3f3f3;
padding-top:4px;
margin:10px;
-moz-border-radius:3px;
-khtml-border-radius:3px;
-webkit-border-radius:3px;
border-radius:3px;
}

.wp-caption img {
margin:0;
padding:0;
border:0 none;
}

.wp-caption-dd {
font-size:11px;
line-height:17px;
padding:0 4px 5px;
margin:0;
}

/* self-clear floats */

.group:after {
content: "."; 
display: block; 
height: 0; 
clear: both; 
visibility: hidden;
}
#content.group .main img{display:none!important;}
#cas_menu{display:none!important;}
#cas_menu ul li a{height:auto!important;}

  </style>
<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Westport CT Medical Malpractice Lawyer &#124; Rich Raphael Attorney Blog &#187; dangerous drug</title>
	<atom:link href="https://www.raphaellaw.com/personal-injury-blog/tag/dangerous-drug/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.raphaellaw.com/personal-injury-blog</link>
	<description></description>
	<lastBuildDate>Sat, 31 Oct 2020 11:46:01 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>https://wordpress.org/?v=4.1.38</generator>
	<item>
		<title>FDA: Common OTC is a Dangerous Drug if Overused</title>
		<link>https://www.raphaellaw.com/personal-injury-blog/2014/01/31/fda-common-otc-dangerous-drug-overused/</link>
		<comments>https://www.raphaellaw.com/personal-injury-blog/2014/01/31/fda-common-otc-dangerous-drug-overused/#comments</comments>
		<pubDate>Fri, 31 Jan 2014 22:23:05 +0000</pubDate>
		<dc:creator><![CDATA[Staff Writer]]></dc:creator>
				<category><![CDATA[Connecticut Medical Malpractice Attorney]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[compensation]]></category>
		<category><![CDATA[dangerous drug]]></category>
		<category><![CDATA[drug lawyer]]></category>
		<category><![CDATA[hospital negligence]]></category>
		<category><![CDATA[medical malpractice attorney]]></category>
		<category><![CDATA[medical product]]></category>
		<category><![CDATA[medical product lawyer]]></category>
		<category><![CDATA[negligence]]></category>
		<category><![CDATA[OTC]]></category>
		<category><![CDATA[overprescribe]]></category>

		<guid isPermaLink="false">https://www.raphaellaw.com/personal-injury-blog/?p=13</guid>
		<description><![CDATA[<p>Some of the most dangerous drugs are those sold over the counter and taken incorrectly. At the end of 2013, the Food and Drug Administration (FDA) issued a warning regarding the overuse of acetaminophen in hospitals and in homes. In January, a similar warning was issued stating that, “over-the-counter (OTC) sodium phosphate drugs to treat [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.raphaellaw.com/personal-injury-blog/2014/01/31/fda-common-otc-dangerous-drug-overused/">FDA: Common OTC is a Dangerous Drug if Overused</a> appeared first on <a rel="nofollow" href="https://www.raphaellaw.com/personal-injury-blog">Westport CT Medical Malpractice Lawyer | Rich Raphael Attorney Blog</a>.</p>
]]></description>
				<content:encoded><![CDATA[<p>Some of the most dangerous drugs are those sold over the counter and taken incorrectly. At the end of 2013, the Food and Drug Administration (FDA) issued a warning regarding the overuse of acetaminophen in hospitals and in homes. In January, a similar warning was issued stating that, “over-the-counter (OTC) sodium phosphate drugs to treat constipation can cause rare but serious harm to the kidneys and heart, and even death,” according to the FDA. The damage results from a change in the levels of serum electrolytes. This can occur if a person takes more than the recommended dose of the sodium phosphate products. “According to the reports,” the FDA states, “most cases of <a href="https://www.raphaellaw.com/medical-malpractice" target="_blank">serious harm</a> occurred with a single dose of sodium phosphate that was larger than recommended or with more than one dose in a day.”</p>
<p><a href="https://www.raphaellaw.com/personal-injury-blog/wp-content/uploads/2014/01/187899848.jpg"><img class="alignright size-medium wp-image-15" style="border: 1px solid white; margin: 5px;" src="https://www.raphaellaw.com/personal-injury-blog/wp-content/uploads/2014/01/187899848-200x300.jpg" alt=" dangerous drug IMAGE" width="200" height="300" /></a><a href="http://www.medscape.org/viewarticle/818571" target="_blank">According to Medscape.org</a>, “the problem surfaced in a review… which turned up 54 cases in 25 adults and 29 children of serious adverse events associated with the oral or rectal use of OTC sodium phosphate drug products used to treat constipation.” Medscape reports that individuals who may be at <a href="https://www.raphaellaw.com/medical-malpractice/surgical-errors" target="_blank">higher risk</a> when using the sodium phosphate products include (but are not limited to):</p>
<ul>
<li>Young children</li>
<li>Individuals older than 55 years</li>
<li>Patients who are dehydrated</li>
<li>Patients with kidney disease, bowel obstruction, inflammation of the bowel</li>
<li>Patients using medications that affect kidney function<span style="line-height: 1.5em;"> </span></li>
</ul>
<p>OTC sodium phosphate medications come in several different forms. They may include diuretics or water pills, Medscape reports, inhibitors or receptor blockers used to treat hypertension, and anti-inflammatory OTC drugs. This isn’t the first time that the FDA has issued a warning regarding the overuse of such drugs, according to Medscape. The agency has previously issued a similar warning regarding the overuse of such drugs “for bowel cleansing before colonoscopy or other procedures,” Medscape reports.</p>
<p>If you or someone you know has been adversely affected because of a dangerous drug in Connecticut, the most important step is to seek legal counsel. <a href="https://www.raphaellaw.com/contact" target="_blank">Contact Richard H. Raphael</a> today.</p>
<p>The post <a rel="nofollow" href="https://www.raphaellaw.com/personal-injury-blog/2014/01/31/fda-common-otc-dangerous-drug-overused/">FDA: Common OTC is a Dangerous Drug if Overused</a> appeared first on <a rel="nofollow" href="https://www.raphaellaw.com/personal-injury-blog">Westport CT Medical Malpractice Lawyer | Rich Raphael Attorney Blog</a>.</p>
]]></content:encoded>
			<wfw:commentRss>https://www.raphaellaw.com/personal-injury-blog/2014/01/31/fda-common-otc-dangerous-drug-overused/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
